Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-02-29 Sale |
2024-03-04 5:30 pm |
Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus Director |
25,000 | $12.41 | $310,309 | 968,311 (Indirect Direct) |
View |
| 2024-01-31 Sale |
2024-02-02 5:00 pm |
Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus Director |
30,000 | $12.79 | $383,550 | 993,311 (Indirect Direct) |
View |
| 2023-12-29 Sale |
2024-01-02 5:30 pm |
Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus Director |
25,000 | $13.38 | $334,500 | 1,023,311 (Indirect Direct) |
View |
| 2023-09-12 Purchase |
2023-12-18 6:30 pm |
Olema Pharmaceuticals Inc. | OLMA | Graham G. Walmsley Director |
640,000 | $10.74 | $6,871,279 | 4,383,875 (Indirect) |
View |
| 2023-12-06 Purchase |
2023-12-08 4:19 pm |
Olema Pharmaceuticals Inc. | OLMA | Paradigm Biocapital Advisors LP Paradigm BioCapital Advisors GP LLC Paradigm BioCapital International Fund Ltd. Asefaw Senai 10% Owner |
100,000 | $11.6 | $1,160,000 | 7,903,600 (Indirect) |
View |
| 2023-11-30 Sale |
2023-12-01 5:15 pm |
Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus Director |
25,000 | $12.57 | $314,250 | 1,048,311 (Indirect Direct) |
View |
| 2023-11-21 Sale |
2023-11-22 7:00 pm |
Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus Director |
8,181 | $14.39 | $117,740 | 1,073,311 (Indirect Direct) |
View |
| 2023-11-21 Sale |
2023-11-22 7:00 pm |
Olema Pharmaceuticals Inc. | OLMA | Zojwalla Naseem CHIEF MEDICAL OFFICER |
14,556 | $14.38 | $209,296 | 30,664 (Direct) |
View |
| 2023-11-21 Sale |
2023-11-22 7:00 pm |
Olema Pharmaceuticals Inc. | OLMA | Myles David C. CH. DISCOV. & NON-CLIN DEV OFF |
13,629 | $14.4 | $196,233 | 741,776 (Indirect Direct) |
View |
| 2023-11-21 Sale |
2023-11-22 7:00 pm |
Olema Pharmaceuticals Inc. | OLMA | Bohen Sean PRESIDENT AND CEO |
57,225 | $14.4 | $824,134 | 144,925 (Direct) |
View |
| 2023-11-21 Sale |
2023-11-22 7:00 pm |
Olema Pharmaceuticals Inc. | OLMA | Kovacs Shane William Charles CH. OPERATING & FINANCIAL OFF. |
18,742 | $14.39 | $269,656 | 424,987 (Direct) |
View |
| 2023-11-08 Sale |
2023-11-13 5:30 pm |
Olema Pharmaceuticals Inc. | OLMA | Myles David C. CH. DISCOV. & NON-CLIN DEV OFF |
200 | $17.61 | $3,522 | 728,947 (Indirect Direct) |
View |
| 2023-11-01 Sale |
2023-11-03 9:39 pm |
Olema Pharmaceuticals Inc. | OLMA | Myles David C. CH. DISCOV. & NON-CLIN DEV OFF |
10,541 | $15.26 | $160,806 | 729,147 (Indirect Direct) |
View |
| 2023-10-31 Sale |
2023-11-02 8:50 pm |
Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus Director |
30,000 | $12.65 | $379,450 | 1,065,742 (Indirect Direct) |
View |
| 2023-09-29 Sale |
2023-10-03 5:00 pm |
Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus Director |
25,000 | $12.41 | $310,250 | 1,095,742 (Indirect Direct) |
View |
| 2023-09-19 Sale |
2023-09-21 5:00 pm |
Olema Pharmaceuticals Inc. | OLMA | Myles David C. CH. DISCOV. & NON-CLIN DEV OFF |
20,000 | $12.67 | $253,400 | 739,688 (Indirect Direct) |
View |
| 2023-09-12 Purchase |
2023-09-14 4:25 pm |
Olema Pharmaceuticals Inc. | OLMA | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N Director 10% Owner |
1,505,932 | $9.84 | $14,818,371 | 852,383 (Indirect Direct) |
View |
| 2023-08-31 Sale |
2023-09-05 9:08 pm |
Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus Director |
25,000 | $10.26 | $256,600 | 1,120,742 (Indirect Direct) |
View |
| 2023-08-16 Sale(A) |
2023-09-05 4:05 pm |
Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus Director |
15,000 | $10.14 | $152,100 | 1,023,714 (Direct) |
View |
| 2023-08-16 Sale |
2023-08-17 5:00 pm |
Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus Director |
15,000 | $10.14 | $152,100 | 1,145,742 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-03-18 Exercise |
2024-03-20 5:30 pm |
N/A N/A |
Olema Pharmaceuticals Inc. | OLMA | Zojwalla Naseem CHIEF MEDICAL OFFICER |
13,700 | $4.87 | 216,664 (Direct) |
View |
| 2024-03-18 Exercise |
2024-03-20 5:30 pm |
N/A 2033-01-31 |
Olema Pharmaceuticals Inc. | OLMA | Zojwalla Naseem CHIEF MEDICAL OFFICER |
13,700 | $0 | 216,664 (Direct) |
View |
| 2024-03-05 Other |
2024-03-06 5:36 pm |
N/A N/A |
Olema Pharmaceuticals Inc. | OLMA | RAPPAPORT ANDREW Director |
866,979 | $0 | 1,252,944 (Indirect) |
View |
| 2024-02-01 Option Award |
2024-02-05 5:30 pm |
N/A 2034-01-31 |
Olema Pharmaceuticals Inc. | OLMA | Myles David C. CH. DISCOV. & NON-CLIN DEV OFF |
195,000 | $0 | 195,000 (Direct) |
View |
| 2024-02-01 Option Award |
2024-02-05 5:30 pm |
N/A 2034-01-31 |
Olema Pharmaceuticals Inc. | OLMA | Zojwalla Naseem CHIEF MEDICAL OFFICER |
195,000 | $0 | 195,000 (Direct) |
View |
| 2024-02-01 Option Award |
2024-02-05 5:30 pm |
N/A 2034-01-31 |
Olema Pharmaceuticals Inc. | OLMA | Kovacs Shane William Charles CH. OPERATING & FINANCIAL OFF. |
304,500 | $0 | 304,500 (Direct) |
View |
| 2024-02-01 Option Award |
2024-02-05 5:30 pm |
N/A 2034-01-31 |
Olema Pharmaceuticals Inc. | OLMA | Bohen Sean PRESIDENT AND CEO |
621,500 | $0 | 621,500 (Direct) |
View |
| 2024-01-25 Exercise |
2024-01-29 07:30 am |
N/A N/A |
Olema Pharmaceuticals Inc. | OLMA | Zojwalla Naseem CHIEF MEDICAL OFFICER |
20,000 | $7.02 | 280,664 (Direct) |
View |
| 2024-01-25 Exercise |
2024-01-29 07:30 am |
N/A 2032-01-31 |
Olema Pharmaceuticals Inc. | OLMA | Zojwalla Naseem CHIEF MEDICAL OFFICER |
20,000 | $0 | 280,664 (Direct) |
View |
| 2024-01-12 Exercise |
2024-01-16 07:30 am |
N/A N/A |
Olema Pharmaceuticals Inc. | OLMA | Kovacs Shane William Charles CH. OPERATING & FINANCIAL OFF. |
50,000 | $7.02 | 671,987 (Direct) |
View |
| 2024-01-12 Exercise |
2024-01-16 07:30 am |
N/A 2032-01-31 |
Olema Pharmaceuticals Inc. | OLMA | Kovacs Shane William Charles CH. OPERATING & FINANCIAL OFF. |
50,000 | $0 | 671,987 (Direct) |
View |
| 2023-12-12 Exercise |
2023-12-12 5:55 pm |
N/A N/A |
Olema Pharmaceuticals Inc. | OLMA | Kovacs Shane William Charles CH. OPERATING & FINANCIAL OFF. |
10,000 | $7.02 | 671,987 (Direct) |
View |
| 2023-12-12 Exercise |
2023-12-12 5:55 pm |
N/A 2032-01-31 |
Olema Pharmaceuticals Inc. | OLMA | Kovacs Shane William Charles CH. OPERATING & FINANCIAL OFF. |
10,000 | $0 | 671,987 (Direct) |
View |
| 2023-12-11 Exercise |
2023-12-12 5:55 pm |
N/A N/A |
Olema Pharmaceuticals Inc. | OLMA | Zojwalla Naseem CHIEF MEDICAL OFFICER |
2,900 | $7.02 | 280,664 (Direct) |
View |
| 2023-12-11 Exercise |
2023-12-12 5:55 pm |
N/A 2032-01-31 |
Olema Pharmaceuticals Inc. | OLMA | Zojwalla Naseem CHIEF MEDICAL OFFICER |
2,900 | $0 | 280,664 (Direct) |
View |
| 2023-12-06 Exercise |
2023-12-07 8:30 pm |
N/A N/A |
Olema Pharmaceuticals Inc. | OLMA | Zojwalla Naseem CHIEF MEDICAL OFFICER |
13,100 | $7.02 | 280,664 (Direct) |
View |
| 2023-12-06 Exercise |
2023-12-07 8:30 pm |
N/A 2032-01-31 |
Olema Pharmaceuticals Inc. | OLMA | Zojwalla Naseem CHIEF MEDICAL OFFICER |
13,100 | $0 | 280,664 (Direct) |
View |
| 2023-11-20 Option Award |
2023-11-22 7:00 pm |
N/A N/A |
Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus Director |
15,750 | $0 | 1,073,311 (Direct) |
View |
| 2023-11-20 Option Award |
2023-11-22 7:00 pm |
N/A N/A |
Olema Pharmaceuticals Inc. | OLMA | Zojwalla Naseem CHIEF MEDICAL OFFICER |
28,000 | $0 | 30,664 (Direct) |
View |
| 2023-11-20 Option Award |
2023-11-22 7:00 pm |
N/A N/A |
Olema Pharmaceuticals Inc. | OLMA | Myles David C. CH. DISCOV. & NON-CLIN DEV OFF |
26,250 | $0 | 741,776 (Direct) |
View |
| 2023-11-20 Option Award |
2023-11-22 7:00 pm |
N/A N/A |
Olema Pharmaceuticals Inc. | OLMA | Bohen Sean PRESIDENT AND CEO |
110,250 | $0 | 144,925 (Direct) |
View |
| 2023-11-20 Option Award |
2023-11-22 7:00 pm |
N/A N/A |
Olema Pharmaceuticals Inc. | OLMA | Kovacs Shane William Charles CH. OPERATING & FINANCIAL OFF. |
36,750 | $0 | 424,987 (Direct) |
View |
| 2023-10-16 Option Award |
2023-10-17 4:43 pm |
N/A 2033-10-15 |
Olema Pharmaceuticals Inc. | OLMA | Garland J. Scott Director |
35,867 | $0 | 35,867 (Direct) |
View |
Ownership |
2023-09-21 5:12 pm |
N/A N/A |
Olema Pharmaceuticals Inc. | OLMA | Paradigm Biocapital Advisors LP Paradigm BioCapital Advisors GP LLC Paradigm BioCapital International Fund Ltd. Asefaw Senai 10% Owner |
0 | $0 | 7,803,600 (Indirect) |
View |
| 2023-09-14 Other |
2023-09-14 4:25 pm |
N/A N/A |
Olema Pharmaceuticals Inc. | OLMA | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N Director 10% Owner |
99,556 | $0 | 852,383 (Indirect) |
View |
| 2023-06-16 Option Award |
2023-06-21 7:14 pm |
N/A 2033-06-15 |
Olema Pharmaceuticals Inc. | OLMA | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N Director 10% Owner |
21,520 | $0 | 7,420,805 (Indirect) |
View |
| 2023-06-16 Option Award |
2023-06-21 5:00 pm |
N/A 2033-06-15 |
Olema Pharmaceuticals Inc. | OLMA | CLARK IAN T Director |
21,520 | $0 | 21,520 (Direct) |
View |
| 2023-06-16 Option Award |
2023-06-21 5:00 pm |
N/A 2033-06-15 |
Olema Pharmaceuticals Inc. | OLMA | Larson Yi Director |
21,520 | $0 | 21,520 (Direct) |
View |
| 2023-06-16 Option Award |
2023-06-21 5:00 pm |
N/A 2033-06-15 |
Olema Pharmaceuticals Inc. | OLMA | Horning Sandra Director |
21,520 | $0 | 21,520 (Direct) |
View |
| 2023-06-16 Option Award |
2023-06-21 5:00 pm |
N/A 2033-06-15 |
Olema Pharmaceuticals Inc. | OLMA | Hrustanovic Gorjan Director |
21,520 | $0 | 21,520 (Direct) |
View |